The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
Written by CannIntelligence || 3rd December 2018 || News analysis | Companies | Health and science | Regulation and legislation | Technology and innovation | Europe